tiprankstipranks
Turnstone Biologics Corp. (TSBX)
NASDAQ:TSBX
US Market
Holding TSBX?
Track your performance easily

Turnstone Biologics Corp. (TSBX) Income Statement

43 Followers

Turnstone Biologics Corp. Income Statement

Last quarter (Q3 2024), Turnstone Biologics Corp.'s total revenue was $135.00K, an increase of Infinity% from previous quarter. In Q3, Turnstone Biologics Corp.'s net income was $-17.03M. See Turnstone Biologics Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23
Total Revenue
$ 19.31M
Cost of Revenue
-
Gross Profit
$ 19.31M
Operating Expense
$ 78.34M
Operating Income
$ -59.03M
Net Non Operating Interest Income Expense
-
Other Income Expense
$ -3.55M
Pretax Income
$ -55.49M
Tax Provision
$ -286.00K
Earnings From Equity Interest Net Of Tax
-
Net Income Common Stockholders
$ -55.24M
Basic EPS
$ -4.78
Diluted EPS
$ -4.78
Basic Average Shares
$ 11.56M
Diluted Average Shares
$ 11.56M
Dividend Per Share
-
Total Operating Income As Reported
-
Reported Normalized Basic E P S
-
Reported Normalized Diluted E P S
-
Rent Expense Supplemental
-
Total Expenses
$ 78.34M
Net Income From Continuing And Discontinued Operation
$ -55.20M
Normalized Income
$ -53.87M
Interest Expense
-
EBIT
$ -55.49M
EBITDA
$ -52.69M
Currency in USD

Turnstone Biologics Corp. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis